Ketoback-DT Tablet contains Ketorolac 10 mg, a potent nonsteroidal anti-inflammatory drug (NSAID) used for the short-term management of moderate to severe pain. Ketorolac exerts its therapeutic effect by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing the synthesis of prostaglandins responsible for inflammation, pain, and fever. This medication is commonly prescribed postoperatively or for acute musculoskeletal pain where opioid analgesics are not indicated or as an adjunct to reduce opioid dosage. Ketoback-DT is indicated for adults requiring short-term analgesia, typically not exceeding five days, to minimize the risk of adverse effects. It should be used with caution in patients with a history of gastrointestinal bleeding, renal impairment, or cardiovascular disease. Common side effects may include gastrointestinal discomfort, nausea, dizziness, and headache. Serious adverse events such as gastrointestinal bleeding, renal toxicity, or hypersensitivity reactions are rare but warrant immediate medical attention. Ketoback-DT is contraindicated in patients with active peptic ulcer disease, bleeding disorders, or known hypersensitivity to ketorolac or other NSAIDs. It is essential to adhere to prescribed dosages and duration to avoid potential toxicity. Consultation with a healthcare professional is advised before initiating therapy, especially in patients with comorbid conditions or concomitant medications.